The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

Objective To assess the thrombotic risk associated with oral contraceptive use with a focus on dose of oestrogen and type of progestogen of oral contraceptives available in the Netherlands.Design Population based case-control study.Setting Six participating anticoagulation clinics in the Netherlands...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 2009-08, Vol.339 (7720), p.561-561
Main Authors: van Hylckama Vlieg, A, Helmerhorst, F M, Vandenbroucke, J P, Doggen, C J M, Rosendaal, F R
Format: Article
Language:English
Subjects:
Acne
Adolescent
Adult
Case control studies
Contraception
Contraceptives, Oral, Hormonal - adverse effects
Contraceptives, Oral, Synthetic - adverse effects
Dosage
Drugs
Drugs: cardiovascular system
Drugs: endocrine system
Drugs: obstetrics and gynaecology
Epidemiologic studies
Estrogens
Estrogens - administration & dosage
Estrogens - adverse effects
Female
Health risk assessment
Hormone replacement therapy
Humans
Medical research
Menopause (including HRT)
Middle Aged
Netherlands
Netherlands - epidemiology
Oestrogen
Oral contraceptives
Pregnancy
Progestins - administration & dosage
Progestins - adverse effects
Progestogen
Pulmonary embolism
Pulmonary Embolism - chemically induced
Pulmonary Embolism - epidemiology
Pulmonary embolisms
Questionnaires
Reproductive medicine
Research universities
Risk Factors
Sexual health
Stroke
Universities
Venous thromboembolism
Venous thrombosis
Venous Thrombosis - chemically induced
Venous Thrombosis - epidemiology
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To assess the thrombotic risk associated with oral contraceptive use with a focus on dose of oestrogen and type of progestogen of oral contraceptives available in the Netherlands.Design Population based case-control study.Setting Six participating anticoagulation clinics in the Netherlands (Amersfoort, Amsterdam, The Hague, Leiden, Rotterdam, and Utrecht).Participants Premenopausal women
ISSN:0959-8138
0959-535X
1468-5833
1756-1833
DOI:10.1136/bmj.b2921